Guidance

Newborn blood spot screening: laboratory guide for IMDs

This publication covers all inherited metabolic diseases (IMDs) and incorporates the previous PKU and MCADD laboratory handbooks.

• From: NHS England
• Published: 14 July 2015
• Last updated: 15 September 2025 — See all updates

Documents

A laboratory guide to newborn blood spot screening for inherited metabolic diseases

HTML

Details

The document covers screening and diagnostic protocols and initial clinical referral guidelines for the inherited metabolic diseases:

• phenylketonuria (PKU)
• medium-chain acyl-CoA dehydrogenase deficiency (MCADD)
• maple syrup urine disease (MSUD)
• isovaleric acidaemia (IVA)
• glutaric aciduria type 1 (GA1)
• homocystinuria (pyridoxine unresponsive) (HCU)
• hereditary tyrosinaemia type 1 (HT1)

Published 14 July 2015

Last updated 15 September 2025 + show all updates

1. 15 September 2025

   Added guidance on hereditary tyrosinaemia type 1 (HT1)

2. 6 November 2024

   Collated information and provided links to diagnostic information

3. 8 September 2017

   Updated version of guidance document.

4. 14 July 2015

   First published.